Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FEHZZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,857
Award facts
- Contract value 100% obligated
- $55,857.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $55,857.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for STELARA 45 mg/0.5 ml syringes on September 24, 2025, with an ultimate completion date of September 25, 2025. STELARA (ustekinumab) is a biologic immunosuppressant medication used to treat conditions including psoriasis, psoriatic arthritis, and Crohn's disease. This non-competitive delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the Defense Health Agency and other federal healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, consistently awarded competitively for delivery of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's extensive federal contract portfolio demonstrates its capability to meet Department of Defense healthcare requirements through its prime vendor arrangement with DLA Troop Support, which supplies pharmaceutical products and medical commodities to support military healthcare programs worldwide. This delivery order for STELARA represents one of numerous competitively awarded actions fulfilling the company's role as a key supplier within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FEHZZ?
SPE2DB25FEHZZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FEHZZ worth?
The government has obligated $55,857 on SPE2DB25FEHZZ.
Is contract SPE2DB25FEHZZ an order under another contract?
Yes. SPE2DB25FEHZZ is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEHZZ competed?
The extent of competition for SPE2DB25FEHZZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award